The germinal center (GC) develops in secondary lymphoid tissues in response to thymusdependent (TD) antigens. To investigate the
Introduction
The germinal centers (GC) develop in the B cell follicles of secondary lymphoid tissues during T cell-dependent (TD) antibody responses (1, 2) . The B cells are activated in the T cell-rich zones by interdigitating cells and T cells, before they migrate into follicles and initiate GC formation (3) (4) (5) (6) . Mature GC consist of dark and light zones. The proliferating blasts, centroblasts, occupy the dark zone and give rise to centrocytes that are not in the cell cycle and fill the light zone. The light zone contains a rich network of follicular dendritic cells GC B cells have been shown to die rapidly by apoptosis in the absence of helper T cells, several biological stimulants could prevent human tonsilar GC B cells from apoptosis or to drive the GC B cells towards proliferative or differentiation pathways (16) . A variety of biological stimulants, including anti-Ig, anti-CD40 mAb (12, 17) , anti-CD38 mAb (18) , anti-CD21 mAb (19) , anti-CD20 mAb (20) , IL-2, IL-4 (21, 22) , granulocyte colony stimulating factor (23) , IL-1α plus soluble CD23 (24) , ICAM-1, VCAM-1 (25) and IL-2 plus IL-10 (16) are able to act on this process. There is considerable evidence in vivo in the mouse that CD40-CD40L interaction is essential for GC formation and the development of B cell memory (26) (27) (28) (29) (30) . However, factors required of mouse GC B cells for differentiation into antibody-forming cells (AFC) still remain to be elucidated.
X chromosome-linked immunodeficient (XID) mice, which have a point mutation in the pleckstrin homology (PH) domain of Bruton's tyrosine kinase (Btk) (31) (32) (33) , are known to have a global B cell defect manifested by low levels of serum IgM and IgG3, failure to respond to type 2 thymus-independent (TI-2) antigen (34, 35) , and impaired responsiveness to cytokines and CD38 (36) (37) (38) (39) (40) . Furthermore, the primary antibody response of XID mice to TD antigen is impaired (41) (42) (43) . It is still controversial, however, whether GC B cells from XID mice respond to CD40 ligation for activation.
In order to clarify the factors required of mouse GC B cells for differentiation into AFC, and to elucidate whether low response of XID mice to TD antigen is due to functional defects of GC B cells, we enriched GC and non-GC B cells from spleen cells of DNP-keyhole limpet hemocyanin (KLH)-immunized BALB/c and BALB/c.xid mice, and examined their responsiveness to CD40 ligation and cytokines leading to differentiation into anti-DNP IgG1-AFC. We provide evidence that IL-4 together with anti-CD40 mAb induces a significant anti-DNP IgG1 response of GC B cells from not only wildtype mice but also XID mice. IL-5 in conjunction with anti-CD40 mAb and IL-4 further enhances the anti-DNP IgG1 response of GC B cells from wild-type, but not of GC B cells from XID mice.
Methods

Animals
BALB/c mice were purchased from the Japan SLC (Hamamatsu, Japan). BALB/c.xid (XID) mice originally provided by Dr Alfred Singer (National Institutes of Health, Bethesda, MD) were maintained in the Animal facility of the Institute of Medical Science, University of Tokyo.
Immunization
Seven-week-old specific pathogen-free female wild-type or XID mice were immunized with 50 µg of DNP-KLH in incomplete Freund's adjuvant by i.p. injection. Mice were boosted with 100 µg of DNP-KLH in saline 4-6 weeks after the primary immunization. Spleens were removed 7 days after the secondary immunization.
Antibodies and reagents
The following mAb were obtained from ATCC (Rockville, MD) and used in this study: RA3/6B2 (anti-B220), 2.4G2 [antimouse (m) FcγR], H57-597 (anti-mTCRβ), GK1.5 (anti-mCD4), 53.6.7 (anti-mCD8), M1/70 (anti-Mac-1) and 53-7.3 (antimCD5). LB429 (44, 45) and 1C10 (46) (anti-mCD40), CS/2 (47) (anti-mCD38) and H7 (48) (anti-mIL-5R α chain, IL-5Rα) were prepared as described. Jo-2 mAb (49) (anti-mFas) was kindly provided by Dr S. Nagata (Osaka University Medical School). For immunofluorescence staining, purified mAb was coupled to biotin (Pierce, Rockford, IL), FITC (Sigma, St Louis, MO) or phycoerythrin (PE; Pierce). Biotinylated AMS9.1 mAb (anti-mIgD a ), biotinylated 8C5 mAb (anti-GR1) and biotinylated anti-mIL-4R mAb were purchased from PharMingen (San Diego, CA). FITC-conjugated peanut agglutinin (PNA) was purchased from Vector (Burlingame, CA). Streptavidin (SA)-PE was purchased from Life Technologies (Tokyo, Japan). SA-allophycocyanin (APC) was purchased from Leinco (Ballwin, MD). SA Indirect Microbeads and anti-FITC Microbeads were purchased from Miltenyi Biotec (BergischGladbach, Germany). Biotin-labeled goat anti-mIgG1 was purchased from Southern Biotechnology Associates (Birmingham, AL). Horseradish peroxidase-conjugated SA (HRPO-SA) was purchased from Zymed (San Francisco, CA). mIL-4 was purchased from R&D Systems (Minneapolis, MN). mIL-5 and sCD40L were purified according to procedures as previously described (50, 51) .
Enrichment of B cell subpopulations
Using a MACS (52) and a FACS Vantage Cell Sorter (Becton Dickinson, Mountain View, CA), B220 ϩ IgD -PNA hi cells were isolated from cell suspensions of spleen from wild-type or XID mice 7 days after the secondary immunization with DNP-KLH. We employed a two-step purification method. In the first step, spleen cells, stained with a cocktail of biotinylated antimIgD a , anti-mTCR-β, anti-mCD4, anti-mCD8, anti-Mac-1 and anti-GR1, and with anti-mFcγR to avoid non-specific binding of the labeled mAb, were incubated with SA-coupled Indirect Microbeads. Cells expressing IgD a , TCRβ, CD4, CD8, Mac-1 or GR1 were depleted using a MACS. In the second step, the cells remained were stained with FITC-conjugated PNA and PE-conjugated anti-B220 followed by SA-APC. The cells thus stained were resuspended in propidium iodide (5 µg/ml) (Sigma) and B220 ϩ IgD -PNA hi cells were sorted with a FACS Vantage. In some experiments, B220 ϩ IgD -PNA hi cells were enriched using a miniMACS (53) . We used these B220 ϩ IgD -PNA hi cells as a source of GC B cells throughout this study. B220 ϩ IgD ϩ cells were isolated by using a MACS column. In brief, cells were stained with biotinylated anti-mIgD a and anti-mFcγR followed by incubation with SA Indirect Microbeads and applied to a MACS column. Adherent IgD ϩ cells were recovered and used as a source of non-GC B cells.
Flow cytometric analysis
Analysis of cell surface markers on B cell subpopulations was carried out by a flow cytometry. Cells were stained with biotinylated mAb followed by SA-APC. After the staining, cells were suspended in the buffer containing propidium iodide (5 µg/ml) to exclude dead cells from the analysis. Florescence intensity was measured on a FACS Vantage. 
Cell culture
After sorting, cells (5ϫ10 4 /0.2 ml/well) were cultured in RPMI 1640 medium supplemented with 10% FCS, 2 µM 2-mercaptoethanol, 100 U/ml penicillin and 100 µg/ml streptomycin for various periods of time. IL-2, IL-4, IL-5, IL-6, IL-10, anti-CD40 mAb (LB429 or 1C10), sCD40L or their combinations were added at the onset of the culture. Each culture was set-up in triplicate. At the end of 7 day culture, the number of anti-DNP IgG1 spot-forming cells was counted by slightly modified ELISPOT assay (54) . In some experiments, we employed the two-step culture system. First, the cells were cultured with various stimuli for 3 days (primary culture) and washed once. Then they were re-cultured for another 4 days (secondary culture) with various stimulants. After the second culture, anti-DNP IgG1-AFC assay was carried out. We repeated each experiment at least three times and one representative result is shown in the text.
Proliferation assay
Cells were inoculated into 96-well microtiter plates at a concentration of 1ϫ10 5 /0.2 ml/well with various concentrations of anti-CD40 mAb or of sCD40L for 3 days. The cells were pulse labeled with 
Anti-DNP IgG1-AFC assay
For determining the number of anti-DNP IgG1-AFC, freshly isolated or cultured GC and non-GC B cells were subjected to an anti-DNP IgG1-specific ELISPOT assay according to a previously described method with a slight modification (54) .
In brief, 96-well Immobilon-P membrane plates (Millipore, Bedford, MA) were coated with DNP-BSA (5 µg/ml) overnight at 4°C. The plates were washed with PBS and incubated for 2 h at 37°C with RPMI 1640 medium containing 10% FCS for blocking. Then the cells were harvested and appropriately diluted with RPMI 1640 with 10% FCS, and were inoculated into individual wells of the membrane plates and incubated for another 4 h. The plates were washed and then incubated with biotinylated goat anti-mIgG1 overnight at 4°C. HRPO-SA was added to each well and incubated for 2 h at 37°C, followed by the addition of 3-amino-9-ethylcarbamazole substrate. Finally spots stained were counted as AFC. No anti-DNP IgG1-AFC was detected on a BSA-coated plate.
Immunohistochemistry and enumeration of GC
For enumeration of GC, immunohistochemical staining was performed as a slightly modified method (55) . Serial 4 µm thick, frozen sections of spleen were cut with a cryostat microtome, mounted onto poly-L-lysine-coated slides, fixed in ice-cold acetone for 15 min and air dried. The sections were incubated with biotinylated PNA and FITC-conjugated anti-B220 mAb, followed by SA-PE. The sections were mounted with 50% glycerin in PBS and were inspected using a MD2000AZ confocal laser microscope (Molecular Dynamics, Sunnyvale, CA). The number of GC was counted as PNAstained areas within anti-B220-stained lymphoid follicles in the sections from five mice per group and expressed as the number per 0.1 mm 2 .
Results
Surface phenotype of GC and non-GC B cells
Histological studies have revealed that GC B cells could be identified by their distinctive affinity for PNA (56) and the lack of surface IgD (57, 58) . Thus, we purified B220 ϩ IgD -PNA hi cells as GC B cells and B220 ϩ IgD ϩ cells as non-GC B cells from mouse spleens 7 days after the secondary immunization with DNP-KLH. For isolation of GC B cells (~1.6% of unfractionated spleen cells), IgD -B cells were enriched by depletion of (IgD a ; TCRβ; CD4; CD8; Mac-1; GR1) ϩ cells using immunomagnetic beads. This enrichment step allowed the isolation of B220 ϩ IgD -PNA hi cells by a sorting step on a FACS Vantage (Fig. 1A) or by immunomagnetic beads enrichment using a miniMACS. In each purification method, the purity of this population was in the range between 88 and 96% (average 94%) and total cell recovery was~30-35% of total B220 ϩ IgD -PNA hi cells in the unseparated population. B220 ϩ IgD ϩ B cells were also isolated from spleens by positive enrichment of IgD ϩ cells using a MACS. The purity of this population was Ͼ93% (average 96%) (Fig. 1B) .
It has been reported that human GC B cells express CD40, Fas and CD38 (16, 17, 59) , and mouse GC B cells express Fas more abundantly than follicular mantle B cells (60) . To investigate the expression of CD40, CD38 and cytokine receptors on mouse GC B cells, GC and non-GC B cells were stained with various mAb, and analyzed on a FACS Vantage. As shown in Fig. 2 , freshly isolated GC B cells, but not non-GC B cells, expressed Fas, in agreement with these studies. The GC B cells significantly expressed CD40, although their mean flourescence intensities were~2-3 times lower than these of non-GC B cells. Interestingly, in contrast to human GC B cells, mouse GC B cells expressed CD38 whose expression was~10 times lower than that of non-GC B cells. Moreover, the GC B cells expressed higher levels of IL-4R than the non-GC B cells. A significant proportion (~4%) of the GC B cells expressed IL-5Rα with high intensity, whereas the proportion of the IL-5Rα ϩ non-GC B cells was Ͻ0.5%. Although a minor population of CD5 ϩ B cells was described in human GC (22) , mouse GC B cells did not show the CD5 expression (data not shown). 
GC and non-GC B cells (5ϫ10 4 /well) were cultured for 3 days in medium alone or in the presence of anti-CD40 (LB429, 1 µg/ml), anti-CD38 (CS/2, 1 µg/ml), IL-4 (50 ng/ml), IL-5 (1000 U/ml) or their combinations. The cultured cells were stained with propidium iodide (2 µg/ml) and the percentages of viable cells were determined by a FACScan. Results are expressed as mean Ϯ SD of triplicate cultures. Representative results of a series of four independent experiments are shown.
Sustained survival of GC B cells in response to anti-CD40 mAb
Similar to human GC B cells, mouse GC B cells died rapidly in culture in the absence of stimulus at 37°C. To examine the effect of anti-CD40 mAb on survival of mouse GC B cells, GC and non-GC B cells were stimulated with anti-CD40, LB429 mAb in the presence or absence of various combinations of cytokines. When GC B cells were stimulated with LB429 mAb for 3 days, percentages of viable cells increased Ͼ70-fold (0.2 versus 14.8%) ( Table 1) 
Anti-DNP IgG1-AFC response of GC B cells
To examine the role of anti-CD40 mAb and cytokines in differentiation of GC B cells in vitro, GC and non-GC B cells were cultured for 7 days in the presence of LB429 mAb, IL-4, IL-5 or their combinations. A significant anti-DNP IgG1-AFC response was observed only when the GC B cells were cultured with LB429 mAb plus IL-4 (Fig. 3A) . Addition of IL-5 in conjunction with IL-4 plus LB429 mAb markedly enhanced the anti-DNP IgG1-AFC response. Stimulation of non-GC B cells with a mixture of LB429 mAb, IL-4 and IL-5 did not induce a significant anti-DNP IgG1-AFC response (Fig. 3A) .
Next, to elucidate the role of LB429 mAb, IL-4 and IL-5 in early phases of the culture for anti-DNP IgG1-AFC response of GC B cells, we employed a two-step culture system. First, the GC B cells were cultured for 3 days (primary culture) with LB429 mAb, IL-4, IL-5 or their combinations, and then the cells were re-stimulated for another 4 days (secondary culture) with a mixture of LB429 mAb, IL-4 and IL-5. As shown in Fig. 3(B) , no anti-DNP IgG1-AFC response was observed in the absence of LB429 mAb in the primary culture, indicating that CD40 ligation is indispensable for this culture system. Stimulation of the cells with LB429 mAb plus IL-4, but not with LB429 mAb plus IL-5, in the primary culture showed the enhanced response. Stimulation of the cells with a mixture of LB429 mAb, IL-4 and IL-5 induced the maximum response.
We then investigated the role of LB429 mAb, IL-4 and IL-5 in the secondary culture. The cells were stimulated with LB429 mAb plus IL-4 in the primary culture for 3 days and stimulated with LB429 mAb, IL-4, IL-5 or their combinations for 4 days in the secondary culture. Stimulation of cells with IL-5, rather than IL-4, together with LB429 mAb in the secondary culture enhanced the anti-DNP IgG1-AFC response (Fig. 3C) . These results suggest that (i) anti-CD40 mAb is required throughout the culture for inducing differentiation of mouse GC B cells into antigen-specific IgG1-AFC, and (ii) IL-4 in the primary culture and IL-5 in the secondary culture efficiently enhance their differentiation.
IL-5R expression on GC B cells after the primary culture
The results of the previous section suggest that CD40 ligation and IL-4 in the primary culture may up-regulate IL-5R expression on GC B cells. To address this issue, we examined the IL-5Rα expression on GC and non-GC B cells after a 3 day culture with various stimuli. Stimulation of GC B cells with IL-4 plus LB429 mAb significantly enhanced the IL-5Rα expression (Fig. 4) , while stimulation with LB429 mAb alone did not enhance the expression. This enhancement was 
GC formation in XID mice
In agreement with previously published results (41-43), we found that XID mice mounted a low anti-DNP IgG1 primary response (~10% of that of wild-type mice) to DNP-KLH immunization and a good secondary anti-DNP IgG1 response (~70% of wild-type mice). We examined the number of GC in the spleen XID mice after DNP-KLH immunization. The number of GC was determined by staining with PNA and anti-B220 Fig. 4 . Expression of IL-5Rα on GC and non-GC B cells from wild-type mice after 3 days of culture. Sorted cells were cultured for 3 days with anti-CD40 mAb (LB429, 1 µg/ml), IL-4 (50 ng/ml), IL-5 (1000 U/ml) or their combinations. Cells were stained with biotinylated H7 (anti-IL-5Rα) mAb followed by SA-APC. Histograms stained with anti-IL-5Rα (solid profiles) are superimposed on those of the negative controls (white profiles). Horizontal and vertical axes illustrate log of fluorescence and relative cell numbers respectively. Representative results of a series of three independent experiments are shown. mAb within lymphoid follicles. The number of GC in spleens of XID mice 10 days after the primary immunization was significantly lower (P Ͻ 0.05) than observed in wild-type mice, whereas the number of GC became comparable to that in wild-type mice 7 days after the secondary immunization (Table  2) . These results were good in agreement with a report by Ridderstad et al. (61) .
Another possibility to explain the low primary antibody response of XID mice to TD antigen is that GC B cells from the immunized XID mice may have aberrant expression of functional molecules which are required for B cell development and activation. Thus, we examined the expression levels of Fas, CD40, CD38, IL-4R and IL-5Rα on GC B cells from XID mice by flow cytometry. The FACS analysis revealed that GC B cells from XID mice expressed comparable levels of Fas, CD40, CD38, IL-4R and IL-5Rα to that seen on GC B cells in wild-type mice (data not shown).
Proliferative response of GC B cells from XID mice to anti-CD40 mAb
B cells from XID mice have been shown to display no proliferative response to anti-CD40 (3/23) mAb, although they show enhanced expression of CD23 and class II MHC antigen (62, 63) . Another report stated that anti-CD40 (1C10) mAb induces proliferation of B cells from XID mice effectively (37, 64) . To evaluate whether our LB429 mAb can trigger GC B cells from XID mice, we stimulated GC as well as non-GC B cells of XID mice with various concentrations of LB429 mAb and examined the proliferative response. As controls, GC and non-GC B cells from wild-type mice were also examined. As shown in Fig. 5 , both GC and non-GC B cells from XID mice proliferated in response to LB429 mAb in a dosedependent manner, although the response of GC B cells was lower than that of non-GC B cells. The proliferative response of B cells from XID mice was always lower at each concentration of LB429 mAb than that of GC B cells from wild-type mice and reached a half-maximum level of that observed in wild-type mice. It was also required Ͼ4 times as much as LB429 mAb to induce the response to a extent similar to that of GC B cells from wild-type mice. We repeated similar experiments using another anti-CD40 mAb, 1C10, and obtained essentially the same results as above (data not shown). These results imply that GC B cells with the xid mutation retain responsiveness to CD40 ligation for proliferation. So we asked whether GC B cells from the immunized XID mouse respond to CD40 for differentiation into IgG1-AFC.
Anti-DNP IgG1 antibody response of GC B cells from XID mice
To examine the anti-DNP IgG1-AFC response of GC B cells from XID mice, we stimulated GC B cells from DNP-KLHimmunized XID mice with anti-CD40 mAb alone, anti-CD40 mAb plus IL-4 or a mixture of anti-CD40 mAb, IL-4 and IL-5. As controls, DNP-KLH primed GC B cells from wildtype mice were also cultured under the same conditions. A significant anti-DNP IgG1-AFC response was observed when GC B cells from not only wild-type but also XID mice were stimulated with IL-4 plus LB429 mAb in a dose-dependent manner ( Table 3 ). The anti-DNP AFC responses induced by LB429 mAb plus IL-4 between XID and wild-type mice showed no significant difference. When GC B cells from wild-type mice were stimulated with a mixture of LB429 mAb, IL-4 and IL-5, they mounted more anti-DNP IgG1-AFC than that induced by anti-CD40 mAb plus IL-4 (P Ͻ 0.04). In contrast, IL-5 did not enhance the response of GC B cells from XID mice under the same culture conditions. Similar results were obtained by using another anti-CD40 mAb, 1C10 (Table 3) , and sCD40L (data not shown) in place of LB429 mAb. Lower amounts of 1C10 mAb than LB429 mAb were effective. However, IL-5 did not enhance the anti-DNP IgG1-AFC response of GC B cells from XID mice in conjunction with 1C10 mAb plus IL-4.
As described in Fig. 4 , stimulation of GC B cells from wildtype mice with LB429 mAb plus IL-4 enhanced the expression of IL-5Rα. Stimulation of GC B cells from XID mice with LB429 mAb plus IL-4 enhanced the expression of IL-5Rα to a similar extent to that of wild-type GC B cells (data not shown). These results indicate that GC B cells from XID mice have the potential to respond to anti-CD40 mAb together with IL-4 for the IgG1-AFC response, but they show impaired responsiveness to IL-5, regardless of enhanced expression of IL-5R in response to anti-CD40 mAb and IL-4.
Discussion
GC is a critical microenvironmental site which develops in secondary lymphoid tissues in response to TD antigen. It has been reported that in vitro survival of human GC B cells can be enhanced upon stimulation with anti-CD40 (G28-5) mAb (12) or CD40L-transfected cells (13) . The addition of IL-4 to anti-CD40 mAb induces the rescued human tonsilar GC B cells in the cell cycle for a few days (21) . In mouse, sCD40L (51) or anti-CD40 mAb (44, 46, 64) directly induces B cell proliferation. When B cells are treated with sCD40L plus cytokines, Ig secretion is observed in a cytokine-dependent and isotype-specific manner (65).
We present four major findings in this study. Since GC B cells have been reported to have a distinctive affinity for PNA and lack sIgD, we enriched the B220 ϩ IgD -PNA hi cells from DNP-KLH-hyperimmunized mice and used them as a source of GC B cells (Fig. 1) . Our system for enrichment of GC B cells is reproducible with good recovery and purity. GC B cells purified in this study bear at least Fas, CD40, IL-4R, IL-5Rα and CD38 molecules on their surface (Fig. 2) . Expression of CD40 and CD38 on GC B cells is lower than non-GC B cells. Human CD38 is reported to be a good marker of GC B cells and plasma cells (16) . In contrast to human CD38 expression at high levels, mouse GC B cells express CD38 only at low levels.
Stimulation of GC B cells with anti-CD38 mAb alone or in concert with IL-4 and IL-5 did not enhance either cell survival (Table 1) or differentiation (data not shown). This is also in sharp contrast to human GC B cells which respond to anti-CD38 mAb for rescue from their apoptosis (18) . Interestingly, non-GC B cells responded to anti-CD38 for the sustained cell viability that was augmented by IL-4 plus IL-5 ( Table 1) . As we reported (36) , stimulation of small dense splenic B cells with anti-CD38 mAb induces a significant proliferative response that is dramatically enhanced by IL-5. Taking all the results together, responsiveness of GC B cells to anti-CD38 mAb appears to be differently regulated in different species (human versus mouse) and mouse CD38 signal may play a distinct role in the triggering of non-GC B cells from GC B cells.
It becomes clear that CD40 ligation and IL-4 are essential for differentiation of mouse GC B cells into antigen-specific IgG1-AFC. To examine the effect of B cell receptor crosslinking on the differentiation of GC B cells, GC B cells from DNP-KLH-primed mice were stimulated with DNP-ovalbumin (2.5 µg/ml) in the presence of anti-CD40 mAb plus IL-4 and the anti-DNP IgG1-AFC response was measured. The addition of DNP-ovalbumin did not enhance the IgG1 response induced by anti-CD40 mAb plus IL-4 (data not shown). We conclude, therefore, that B cell receptor cross-linking is not necessary for the differentiation of GC B cells in our culture system. We do not have any evidence for the involvement of follicular dendritic cells in our culture system. This issue will be analyzed in future. Arpin et al. have demonstrated that IL-2-, IL-10-and CD40L-expressing cells are able to induce human GC B cells into memory B cells or plasma cells in vitro (16) . From our findings, stimulation of mouse GC B cells with IL-2, IL-6 or IL-10 together with anti-CD40 mAb, or with their combination, was ineffective (data not shown). The nature of cytokines required for mouse GC B cell differentiation may differ from these for human GC B cells.
We and others reported that IL-5 is one of the most potent cytokines which can induce proliferation and terminal differentiation of activated mouse B cells (66) (67) (68) (65) . Our results are in agreement with theirs (data not shown). We infer from these results that antigen-specific memory B cells are preferentially enriched in GC which are able to be activated by CD40 ligation plus IL-4. IL-5 is not an essential cytokine for GC B cell differentiation, but is a cytokine required for augmenting the response.
Conventional B cells as well as B-1 cells from XID mice have been reported to show low responses to various antigens or stimulants (31) (32) (33) (34) (35) (36) (37) (38) 70) . It still remains elusive whether XID B cells respond to anti-CD40 mAb for proliferation and differentiation into Ig-secreting cells in conjunction with cytokines. Hasbold et al. (62, 63) have demonstrated that anti-CD40 mAb shows weak mitogenic activity by itself for B cell proliferation and does not induce a proliferative response of XID B cells even in the presence of IL-4. In contrast, Lund et al. (37, 64) have reported that substantial proliferative responses of XID B cells are induced by anti-CD40 mAb. As shown in Fig. 5 , GC as well as non-GC B cells from XID mice significantly responded to CD40 ligation by either LB429 or 1C10 mAb, resulting in the induction of proliferation, although the magnitude of the proliferative response of XID B cells at each given dose of the mAb was lower than that of wild-type B cells. These results appear to be different from those described by Hasbold et al. (62) . We do not have good explanations for the differences between our results and theirs. It may be due to differences of the culture system employed or by differences of binding affinity of our anti-CD40 mAb to CD40 from theirs. Importantly, the peak proliferative response of XID B cells was about half of wild-type B cells. GC B cells from XID mice may respond poorly to anti-CD40 mAb than GC B cells from wild-type mice or a subpopulation of GC B cells from XID mice might respond poorly to anti-CD40 mAb.
The GC B cells from DNP-KLH-primed XID mice were able to respond to anti-CD40 mAb plus IL-4 for their differentiation into anti-DNP IgG1-AFC (Table 3 ). This is a really intriguing observation. Importantly, IL-5 did not amplify the anti-DNP IgG1-AFC response, induced by anti-CD40 mAb plus IL-4. This was in sharp contrast to GC B cells from wild-type mice. GC B cells from XID mice were able to express IL-5Rα in response to anti-CD40 mAb and IL-4 to a extent similar to GC B cells from wild-type mice. As we reported previously (38, 68) , splenic B cells as well as B-1 cells in peritoneal washouts do not respond to IL-5 for differentiation, although they express IL-5R. Thus, results obtained in this study are consistent to our previous results.
To evaluate a role of IL-5 in differentiation of GC B cells, we immunized IL-5Rα-deficient mice with DNP-KLH and titrated the anti-DNP IgG1 response in the serum. We also examined responsiveness of GC B cells to anti-CD40 mAb plus IL-4 for anti-DNP IgG1-AFC response. Our analyses revealed that IL-5Rα-deficient mice showed slightly decreased primary anti-DNP IgM and comparable secondary anti-DNP IgG1 response to wild-type mice. Purified GC B cells from IL-5Rα-deficient mice responded to anti-CD40 mAb plus IL-4 for anti-DNP IgG1-AFC to a slightly lesser extent to these from wild-type mice (data not shown). As expected, IL-5 did not enhance the anti-DNP IgG1-AFC response of GC B cells from IL-5Rα-deficient mice. These results and the results obtained using GC B cells from XID mice suggest that cytokines other than IL-5 may play a role in inducing terminal differentiation of GC B cells in XID mice in vivo. Alternatively, IL-5 might not play a crucial role in GC B cell differentiation in vivo.
Functional defects of B cells from XID mice have been shown to be due to a point mutation in the PH domain of Btk. As GC B cells from XID mice respond to anti-CD40 mAb, there exists a CD40 signaling pathway(s) which does not involve Btk. However, considering that GC B cells from XID mice show lower proliferative responses to anti-CD40 mAb than those from wild-type mice, there may exist a pathway that involves Btk. Taken together, there are at least two different pathways for CD40 signaling; one of them is Btk dependent and the other is Btk independent. We are currently studying the Btk-dependent pathway in more detail.
In conclusion, we found the crucial role of CD40 signaling for mouse GC B cell activation which required the costimulatory contribution of IL-4 and further amplification by IL-5. GC B cells from XID mice respond to anti-CD40 mAb and IL-4; however, further amplification by IL-5 is not observed. A further study of the identification of CD40-associated molecules, and molecular mechanisms underlying differentiation and prevention of GC B cells from apoptosis should provide an important opportunity for understanding the role of CD40 ligation, IL-4 and IL-5 in B cell differentiation in GC.
